Journal of Clinical Pediatrics >
Clinical analysis of 51 cases of acute lymphoblastic leukemia with seizures in children
Received date: 2021-07-27
Online published: 2022-02-11
Objective To analyze the clinical characteristics of seizures in children with acute lymphoblastic leukemia (ALL) during treatment. Methods The clinical data of children diagnosed with ALL complicated with seizures from January 2011 to June 2019 were analyzed retrospectively. Results A total of 978 children with ALL were admitted, of which 51 (5.2%) developed seizure symptoms after ALL treatment, 39 males and 12 females, with a median age of 7.4 years (3.7-11.1). Their common etiologies were chemical drug neurotoxicity (12 cases), intracranial hemorrhage (7 cases), hyponatremia (6 cases), white matter encephalopathy (5 cases), febrile convulsions (5 cases), and reversible posterior encephalopathy syndrome (4 cases). First seizures were relatively common with generalized seizures, and depending on the cause of the seizures, they were often accompanied by impaired consciousness, focal symptoms and other clinical features. A total of 39 children in this group underwent cranial CT or MRI after the first seizure, and 27 were abnormal. In the 30 cases with successful follow-up, 14 cases had abnormal imaging, including 8 cases with reversible foci and 4 cases with cerebral softening foci. Twenty-eight cases had abnormal EEG results after the first seizure, mainly with medium-high amplitude slow wave emission. Of the 30 children successfully followed up, 18 had no significant sequelae. Conclusion Seizures are common neurological complications in children with ALL during treatment. The etiology of the first seizure and its accompanying clinical characteristics are diverse. Timely neuroimaging and EEG examinations are helpful for early diagnosis and treatment.
Key words: Acute lymphoblastic leukemia; Seizures; Clinical characteristics; Prognosis; Child
Min XU , Wenjie ZHOU , Jihong TANG , Xiaoyan SHI , Bingbing ZHANG , Xiao XIAO . Clinical analysis of 51 cases of acute lymphoblastic leukemia with seizures in children[J]. Journal of Clinical Pediatrics, 2022 , 40(2) : 118 -122 . DOI: 10.12372/jcp.2022.21e1106
[1] | Maxwell RR, Cole PD. Pharmacogenetic predictors of treatment-related toxicity among children with acute lymphoblastic leukemia[J]. Curr Hematol Malig Rep, 2017, 12(3):176-186. |
[2] | Tang JH, Tian JM, Sheng M, et al. Study of posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia after induction chemotherapy[J]. J Child Neurol, 2016, 31(3):279-284. |
[3] | Maytal J, Grossman R, Yusuf FH, et al. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia[J]. Epilepsia, 1995, 36(8):831-836. |
[4] | Goyal M, Bangert BA, Wiznitzer M. Mesial temporal sclerosis in acute childhood leukemias[J]. Epilepsia, 2003, 44(1):131-134. |
[5] | Anastasopoulou S, Heyman M, Eriksson MA, et al. Seizures during treatment of childhood acute lymphoblastic leukemia: a population-based cohort study[J]. Eur J Paediatr Neurol, 2020, 27:72-77. |
[6] | Rao RD, Swanson JW, Dejesus RS, et al. Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia[J]. Leuk Lymphoma, 2002, 43(6):1333-1336. |
[7] | 陈波, 宪莹, 苏庸春, 等. CCLG-ALL 08方案治疗儿童急性淋巴细胞白血病毒副作用的临床研究[J]. 中国当代儿科杂志, 2013, 15(9):737-742. |
[8] | 许凤玲, 管贤敏, 温贤浩, 等. 儿童急性淋巴细胞白血病化疗相关严重不良反应的临床分析[J]. 中国当代儿科杂志, 2020, 22(8):828-833. |
[9] | Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy[J]. Epilepsia, 2014, 55(4):475-482. |
[10] | 吴立文, 金丽日. 解读新的癫痫临床实用性定义[J]. 中华神经科杂志, 2014, 47(8):513-515. |
[11] | Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2010, 10(5):317-328. |
[12] | Baytan B, Evim MS, Güler S, et al. Acute central nervous system complications in pediatric acute lymphoblastic leukemia[J]. Pediatr Neurol, 2015, 53(4):312-318. |
[13] | Millan NC, Pastrana A, Guitter MR, et al. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia[J]. Leuk Res, 2018, 65:86-93. |
[14] | Nassar SL, Conklin HM, Zhou Y, et al. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2017, 64(8):10. |
[15] | Andrés-Jensen L, Attarbaschi A, Bardi E, et al. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia[J]. Lancet Haematol, 2021, 8(7):e513-e523. |
[16] | Parasole R, Petruzziello F, Menna G, et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution[J]. Leuk Lymphoma, 2010, 51(6):1063-1071. |
[17] | Hamamoto K, Oriuchi N, Kanazawa T, et al. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy[J]. Pediatr Neurol, 2009, 40(4):306-309. |
[18] | Hammad MY. Frenkel EP, Bick R. L-asparaginase-provoked seizures as singular expression of central nervous toxicity[J]. Clin Appl Thromb Hemost, 2000, 6(4):234-238. |
[19] | Mahapatra M, Kumar R, Choudhry VP. Seizures as an adverse drug reaction after therapeutic dose of vincristine[J]. Ann Hematol, 2007, 86(2):153-154. |
[20] | 刘素香, 肖佩芳, 胡绍燕, 等. 儿童造血干细胞移植后神经系统并发症的临床分析[J]. 中华器官移植杂志, 2019, 40(11):691-695. |
[21] | Antunes NL. Seizures in children with systemic cancer[J]. Pediatr Neurol, 2003, 28(3):190-193. |
[22] | Kishi S, Griener J, Cheng C, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia[J]. J Clin Oncol, 2003, 21(16):3084-3091. |
[23] | Banerjee JS, Heyman M, Palomäki M, et al. Posterior reversible encephalopathy syndrome: risk factors and impact on the outcome in children with acute lymphoblastic leukemia treated with nordic protocols[J]. J Pediatr Hematol Oncol, 2018, 40(1):e13-e18. |
[24] | 张雷, 吴学东. 儿童急性淋巴细胞白血病合并可逆性后部脑病综合征2例并文献复习[J]. 亚洲儿科病例研究, 2020, 8(2):13-17. |
[25] | Anastasopoulou S, Eriksson MA, Heyman M, et al. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: clinical characteristics, risk factors, course, and outcome of disease[J]. Pediatr Blood Cancer, 2019, 66(5):e27594. |
[26] | Goldberg-Stern H, Cohen R, Pollak L, et al. The mystery of electroencephalography in acute lymphoblastic leukemia[J]. Seizure, 2011, 20(3):194-196. |
[27] | Guruprasad CS, Binitha R, Nair M, et al. Etiological profile of seizures in children undergoing chemotherapy for acute lymphoblastic leukemia[J]. Pediatr Hematol Oncol J, 2016, 1(2):S12. |
[28] | Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics[J]. Clin Ther, 2008, 30(8):1385-1407. |
/
〈 |
|
〉 |